Broughton Laboratories and Nerudia have today announced a new partnership which will see the companies working in tandem to support customers in complying with the requirements of the European Tobacco Products Directive (TPD), which comes into effect on 20 May 2016.
The partnership brings the strengths and expertise of the two companies together and will bring cost benefits to customers through economies of scale and knowledge, along with the convenience of having a single point of contact between the two businesses.
Peter Beckett, Nerudia Head of Compliance, said ‘The analytical capabilities and expertise of Broughton Laboratories are a perfect fit with Nerudia’s regulatory knowledge and our own services. Our partnership will bring cost effective and accessible services to the entire market, from the smaller firms up to larger organisations, as we believe that the cost of TPD should not be prohibitive to anyone’.
Chris Allen, MD of Broughton Laboratories commented ‘The partnership of Nerudia and Broughton Laboratories means that clients will receive a premium level of service for both regulatory support and emissions testing studies for EU TPD compliance. Combining our experience and expertise of working within global regulated industries enables us to offer clients a pragmatic and scientifically-sound approach to complying with the EU TPD regulations. Alongside Nerudia Compliance we will continue to work closely with the MHRA and other EU Member States to develop, establish and promote international quality standards for the electronic cigarette industry. We believe this will help our clients achieve success’.
To mark the partnership there will be an offer of 10% discount on all analytical and regulatory services booked during March.
For further information please contact email@example.com